Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Nutt

Showing results (181-190 of 389) with videos related to

Pageof 39
Sort By:
Journal of Psychopharmacology (Oxford, England)|January 28, 2024
Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey studyJessica Barbut Siva, Tommaso Barba, Hannes Kettner, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 7, 2005
Comparison of alterations in c-fos and Egr-1 (zif268) expression throughout the rat brain following acute administration of different classes of antidepressant compoundsDavid A Slattery, John A Morrow, Alan L Hudson, et al.
Drug and Alcohol Dependence|December 3, 2019
The development and validation of a human screening model of tobacco abstinenceMeryem Grabski, H Valerie Curran, David J Nutt, et al.
Journal of Psychopharmacology (Oxford, England)|December 10, 2015
Effect of short-term escitalopram treatment on neural activation during emotional processingEduard Maron, Matt Wall, Ray Norbury, et al.
Journal of Psychopharmacology (Oxford, England)|June 21, 2017
Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individualsFergus D Law, Alison M Diaper, Jan K Melichar, et al.
Journal of Psychopharmacology (Oxford, England)|December 13, 2021
Debunking the myth of 'Blue Mondays': No evidence of affect drop after taking clinical MDMABen Sessa, Jacob S Aday, Steve O'Brien, et al.
Journal of Psychopharmacology (Oxford, England)|March 18, 2010
Effects of 7.5% CO2 challenge in generalized anxiety disorderKate Seddon, Kelly Morris, Jayne Bailey, et al.
Journal of Psychopharmacology (Oxford, England)|April 13, 2002
Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetineCaroline Bell, Sam Forshall, Mariona Adrover, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 15, 2010
GABAergic control of novelty stress-responsive epigenetic and gene expression mechanisms in the rat dentate gyrusAndreas Papadopoulos, Yalini Chandramohan, Andrew Collins, et al.
Journal of Psychopharmacology (Oxford, England)|July 19, 2015
Evidence for serotonin function as a neurochemical difference between fear and anxiety disorders in humans?Felipe Corchs, David J Nutt, Dana A Hince, et al.
Pageof 39

Showing results (181-190 of 389) with videos related to

Sort By:
Pageof 39
Journal of Psychopharmacology (Oxford, England)|January 28, 2024
Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey studyJessica Barbut Siva, Tommaso Barba, Hannes Kettner, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 7, 2005
Comparison of alterations in c-fos and Egr-1 (zif268) expression throughout the rat brain following acute administration of different classes of antidepressant compoundsDavid A Slattery, John A Morrow, Alan L Hudson, et al.
Drug and Alcohol Dependence|December 3, 2019
The development and validation of a human screening model of tobacco abstinenceMeryem Grabski, H Valerie Curran, David J Nutt, et al.
Journal of Psychopharmacology (Oxford, England)|December 10, 2015
Effect of short-term escitalopram treatment on neural activation during emotional processingEduard Maron, Matt Wall, Ray Norbury, et al.
Journal of Psychopharmacology (Oxford, England)|June 21, 2017
Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individualsFergus D Law, Alison M Diaper, Jan K Melichar, et al.
Journal of Psychopharmacology (Oxford, England)|December 13, 2021
Debunking the myth of 'Blue Mondays': No evidence of affect drop after taking clinical MDMABen Sessa, Jacob S Aday, Steve O'Brien, et al.
Journal of Psychopharmacology (Oxford, England)|March 18, 2010
Effects of 7.5% CO2 challenge in generalized anxiety disorderKate Seddon, Kelly Morris, Jayne Bailey, et al.
Journal of Psychopharmacology (Oxford, England)|April 13, 2002
Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetineCaroline Bell, Sam Forshall, Mariona Adrover, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 15, 2010
GABAergic control of novelty stress-responsive epigenetic and gene expression mechanisms in the rat dentate gyrusAndreas Papadopoulos, Yalini Chandramohan, Andrew Collins, et al.
Journal of Psychopharmacology (Oxford, England)|July 19, 2015
Evidence for serotonin function as a neurochemical difference between fear and anxiety disorders in humans?Felipe Corchs, David J Nutt, Dana A Hince, et al.
Pageof 39